PMID- 36170129
OWN - NLM
STAT- MEDLINE
DCOM- 20220930
LR  - 20220930
IS  - 1660-9379 (Print)
IS  - 1660-9379 (Linking)
VI  - 18
IP  - 797
DP  - 2022 Sep 28
TI  - [Dyspepsia: a more complex approach].
PG  - 1784-1787
LID - 10.53738/REVMED.2022.18.797.1784 [doi]
AB  - Dyspepsia is defined as epigastric pain that lasts at least one month and may be 
      associated with a range of other upper gastrointestinal symptoms. Approximately 
      2/3 of outpatients with dyspepsia have a functional dyspepsia. The clinical 
      assessment of dyspepsia is based on age of patients as well and the search for 
      severity criteria. The endoscopy in cases of new-onset dyspepsia is recommended 
      from an age of 55-60 and the presence of at least 1 severity criteria. A 
      non-invasive test for Helicobacter pylori (HP) should be performed in all 
      patients and followed by HP eradication when HP test is positive. The 
      first-choice treatment of functional dyspepsia is a proton pump inhibitor (PPI) 
      at maximal dose for 8 weeks. A therapeutic trial with a prokinetic or a central 
      neuromodulator are alternatives to consider in case of failure of PPI treatment.
FAU - Mbadu Mbuzi, Eminence
AU  - Mbadu Mbuzi E
AD  - Service de medecine de premier recours, Hopitaux universitaires de Geneve, 1211 
      Geneve 14.
FAU - Weber, Irene Paola
AU  - Weber IP
AD  - Service de medecine de premier recours, Hopitaux universitaires de Geneve, 1211 
      Geneve 14.
FAU - Humair, Jean-Paul
AU  - Humair JP
AD  - Service de medecine de premier recours, Hopitaux universitaires de Geneve, 1211 
      Geneve 14.
FAU - Gillabert, Cedric
AU  - Gillabert C
AD  - Centre medical de Lancy, Route de Chancy 59C, 1213 Petit-Lancy.
FAU - Bastid, Caroline
AU  - Bastid C
AD  - Service de gastroenterologie et hepatologie, Hopitaux universitaires de Geneve, 
      1211 Geneve 14.
LA  - fre
PT  - Journal Article
TT  - Dyspepsie: une approche plus complexe.
PL  - Switzerland
TA  - Rev Med Suisse
JT  - Revue medicale suisse
JID - 101219148
RN  - 0 (Proton Pump Inhibitors)
SB  - IM
MH  - *Dyspepsia/diagnosis/etiology/therapy
MH  - *Gastritis/diagnosis/drug therapy
MH  - *Helicobacter Infections/complications/diagnosis/drug therapy
MH  - *Helicobacter pylori
MH  - Humans
MH  - Proton Pump Inhibitors/therapeutic use
COIS- Les auteurs n'ont declare aucun conflit d'interets en relation avec cet article.
EDAT- 2022/09/29 06:00
MHDA- 2022/10/01 06:00
CRDT- 2022/09/28 12:43
PHST- 2022/09/28 12:43 [entrez]
PHST- 2022/09/29 06:00 [pubmed]
PHST- 2022/10/01 06:00 [medline]
AID - RMS0797-003 [pii]
AID - 10.53738/REVMED.2022.18.797.1784 [doi]
PST - ppublish
SO  - Rev Med Suisse. 2022 Sep 28;18(797):1784-1787. doi: 
      10.53738/REVMED.2022.18.797.1784.